Rajneesh Nath, MD, medical oncologist at the Banner MD Anderson Cancer Center, discusses early results from the phase 3 SIERRA trial investigating the efficacy of Iomab-B and protocol-specified…
Based on results from an earlier study led by Dr Isamu Okamoto of the Graduate School of Medical Sciences at Kyushu University in Fukuoka, Japan that found progression-free…
Doctors Drilon, Rotow, Stinchcombe, and Saxena participated in a roundtable discussion about therapies targeting certain biomarkers in patients with non-small cell lung cancer (NSCLC). The expert panel agrees…
Terence T. Sio, MD, MS, associate professor of radiation oncology at the Mayo Clinic and specialist in both X-ray-based and proton radiotherapies, discusses study results comparing the efficacy…
In this video, Benjamin P. Levy, MD, assistant professor of oncology and clinical director of Medical Oncology for the Sidney Kimmel Cancer Center at Johns Hopkins Medicine, stresses…
Join Michael Hochman, MD, MPH, for the second episode of Updates in Slow Medicine. This installment discusses results from a recent study that raises the possibility that a…
Results from a cohort study suggest that vision loss, a common side effect after plaque radiotherapy for uveal melanoma, may be mitigated or avoided entirely thanks to prophylactic…
The constantly evolving science and emerging study results focused on adjuvant therapies have drastically changed the treatment landscape for patients with melanoma. Along with targeted therapies, immunotherapies have…
After prior case studies showed promising results with PD-1 inhibition followed by chemotherapy, a group of doctors, led by Georgia Sofia Karachaliou, MD, MSc, of the Department of Medicine…
A new analysis published in European Urology suggests that the risk window of recurrence for surgically treated renal cell carcinoma (RCC) may be longer than previously thought. Hoping…
